Chris Rowe1, Glenn-Milo Santos1, Willi McFarland1, Erin C Wilson2. 1. Center for Public Health Research, San Francisco Department of Public Health, 25 Van Ness Avenue, San Francisco, CA 94102, United States. 2. Center for Public Health Research, San Francisco Department of Public Health, 25 Van Ness Avenue, San Francisco, CA 94102, United States. Electronic address: erincwilson@gmail.com.
Abstract
BACKGROUND: Substance use is highly prevalent among transgender (trans*) females and has been associated with negative health outcomes, including HIV infection. Little is known about psychosocial risk factors that may influence the onset of substance use among trans*female youth, which can contribute to health disparities during adulthood. METHODS: We conducted a secondary data analysis of a study on HIV risk and resilience among trans*female youth (N=292). Prevalence of substance use was assessed and multivariable logistic regression models were used to examine the relationship between posttraumatic stress disorder (PTSD), psychological distress, gender-related discrimination, parental drug or alcohol problems (PDAP) and multiple substance use outcomes. RESULTS: Most (69%) of the trans*female youth reported recent drug use. In multivariable analyses, those with PTSD had increased odds of drug use [AOR=1.94 (95% CI=1.09-3.44)]. Those who experienced gender-related discrimination had increased odds of drug use [AOR=2.28 (95% CI=1.17-4.44)], drug use concurrent with sex [AOR=2.35 (95% CI=1.11-4.98)] and use of multiple drugs [AOR=3.24 (95% CI=1.52-6.88)]. Those with psychological distress had increased odds of using multiple heavy drugs [AOR=2.27 (95% CI=1.01-5.12)]. Those with PDAP had increased odds of drugs use [AOR=2.62 (95% CI=1.43-4.82)], drug use concurrent with sex [AOR=2.01 (95% CI, 1.15-3.51)] and use of multiple drugs [AOR=2.10 (95% CI=1.22-3.62)]. CONCLUSIONS: Substance use is highly prevalent among trans*female youth and was significantly associated with psychosocial risk factors. In order to effectively address substance use among trans*female youth, efforts must address coping related to gender-based discrimination and trauma. Furthermore, structural level interventions aiming to reduce stigma and gender-identity discrimination might also be effective.
BACKGROUND: Substance use is highly prevalent among transgender (trans*) females and has been associated with negative health outcomes, including HIV infection. Little is known about psychosocial risk factors that may influence the onset of substance use among trans*female youth, which can contribute to health disparities during adulthood. METHODS: We conducted a secondary data analysis of a study on HIV risk and resilience among trans*female youth (N=292). Prevalence of substance use was assessed and multivariable logistic regression models were used to examine the relationship between posttraumatic stress disorder (PTSD), psychological distress, gender-related discrimination, parental drug or alcohol problems (PDAP) and multiple substance use outcomes. RESULTS: Most (69%) of the trans*female youth reported recent drug use. In multivariable analyses, those with PTSD had increased odds of drug use [AOR=1.94 (95% CI=1.09-3.44)]. Those who experienced gender-related discrimination had increased odds of drug use [AOR=2.28 (95% CI=1.17-4.44)], drug use concurrent with sex [AOR=2.35 (95% CI=1.11-4.98)] and use of multiple drugs [AOR=3.24 (95% CI=1.52-6.88)]. Those with psychological distress had increased odds of using multiple heavy drugs [AOR=2.27 (95% CI=1.01-5.12)]. Those with PDAP had increased odds of drugs use [AOR=2.62 (95% CI=1.43-4.82)], drug use concurrent with sex [AOR=2.01 (95% CI, 1.15-3.51)] and use of multiple drugs [AOR=2.10 (95% CI=1.22-3.62)]. CONCLUSIONS: Substance use is highly prevalent among trans*female youth and was significantly associated with psychosocial risk factors. In order to effectively address substance use among trans*female youth, efforts must address coping related to gender-based discrimination and trauma. Furthermore, structural level interventions aiming to reduce stigma and gender-identity discrimination might also be effective.
Authors: Meg Gerrard; Michelle L Stock; Megan E Roberts; Frederick X Gibbons; Ross E O'Hara; Chih-Yuan Weng; Thomas A Wills Journal: Psychol Addict Behav Date: 2012-04-30
Authors: Brandon D L Marshall; Evan Wood; Jean A Shoveller; Thomas L Patterson; Julio S G Montaner; Thomas Kerr Journal: BMC Public Health Date: 2011-01-07 Impact factor: 3.295
Authors: Erin C Wilson; Robert Garofalo; Robert D Harris; Amy Herrick; Miguel Martinez; Jaime Martinez; Marvin Belzer Journal: AIDS Behav Date: 2009-02-06
Authors: Marla E Eisenberg; Amy L Gower; Barbara J McMorris; G Nicole Rider; Glynis Shea; Eli Coleman Journal: J Adolesc Health Date: 2017-07-21 Impact factor: 5.012
Authors: Sari L Reisner; Laura Jadwin-Cakmak; Lauren Sava; ShanShan Liu; Gary W Harper Journal: AIDS Patient Care STDS Date: 2019-03 Impact factor: 5.078
Authors: Paul A Gilbert; Lauren E Pass; Alex S Keuroghlian; Tom K Greenfield; Sari L Reisner Journal: Drug Alcohol Depend Date: 2018-03-10 Impact factor: 4.492
Authors: Noor Beckwith; Michal J McDowell; Sari L Reisner; Shayne Zaslow; Roger D Weiss; Kenneth H Mayer; Alex S Keuroghlian Journal: LGBT Health Date: 2019-02-01 Impact factor: 4.151